Publicacións (49) Publicacións nas que participase algún/ha investigador/a Ver datos de investigación referenciados.

filter_list Microbiology (medical)

2025

  1. A 28-Year Multicenter Cohort Study of Nontuberculous Mycobacterial Lymphadenitis in Children, Spain

    Emerging Infectious Diseases, Vol. 31, Núm. 3, pp. 536-546

  2. A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age

    Infectious Diseases and Therapy, Vol. 14, Núm. 2, pp. 463-481

2024

  1. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

    The Journal of experimental medicine, Vol. 221, Núm. 2

  2. Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children

    The Lancet, Vol. 404, Núm. 10458, pp. 1157-1170

  3. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

    The Journal of infectious diseases, Vol. 229, Núm. 1, pp. 95-107

  4. Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study

    Journal of Infectious Diseases

  5. Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Relationship between molecular pathogen detection and clinical disease in febrile children across Europe: a multicentre, prospective observational study

    The Lancet Regional Health - Europe, Vol. 32

  2. The Path Towards Effective Respiratory Syncytial Virus Immunization Policies: Recommended Actions

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 581-588

  3. Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness

    Expert review of vaccines, Vol. 22, Núm. 1, pp. 738-748

2022

  1. Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis

    Journal of Infectious Diseases, Vol. 226, pp. S29-S37

  2. Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study

    Pediatric Critical Care Medicine, Vol. 23, Núm. 12, pp. E543-E554

  3. Risk Analysis by Age on the Burden of Meningococcal Disease in Spain

    Vaccines, Vol. 10, Núm. 4

2021

  1. Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children

    Journal of Pediatrics, Vol. 236, pp. 211-218.e2

2020

  1. Host Transcriptomic Response Following Administration of Rotavirus Vaccine in Infants’ Mimics Wild Type Infection

    Frontiers in Immunology, Vol. 11

  2. Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU)

    The Journal of infectious diseases, Vol. 222, Núm. 7, pp. S658-S665

  3. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

    The New England journal of medicine, Vol. 383, Núm. 5, pp. 426-439

  4. Role of monocytes/macrophages in COVID-19 pathogenesis: Implications for therapy

    Infection and Drug Resistance, Vol. 13, pp. 2485-2493

  5. Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain

    Human Vaccines and Immunotherapeutics, Vol. 16, Núm. 6, pp. 1446-1453

2019

  1. A qPCR expression assay of IFI44L gene differentiates viral from bacterial infections in febrile children

    Scientific Reports, Vol. 9, Núm. 1